Importance of response to neoadjuvant chemotherapy in potentially curable colorectal cancer liver metastases View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2008-04-25

AUTHORS

Birgit Gruenberger, Werner Scheithauer, Robert Punzengruber, Christoph Zielinski, Dietmar Tamandl, Thomas Gruenberger

ABSTRACT

BACKGROUND: Surgical resection of liver metastases arising from colorectal cancer is considered the only curative treatment option. However, many patients subsequently experience disease recurrence. We prospectively investigated whether neoadjuvant chemotherapy reduces the risk of recurrence following potentially curative liver resection. Special emphasis was directed to the importance of response. METHODS: 50 patients with resectable liver metastases received neoadjuvant XELOX or FOLFOX4 for six cycles (3 months). Complete resection of liver metastases was intended thereafter. Assessments included response rate, postoperative morbidity and recurrence-free survival. RESULTS: An objective response was observed in 72% of all patients, including two complete responses. Chemotherapy was well tolerated and the majority of adverse events were mild to moderate (grade 1/2). Potentially curative R0 resection was performed in all patients and postoperative complications were observed in only 12%. The median recurrence-free survival was significantly influenced by tumor response with 24.7 months (95% CI: 4.50 to 44.97) in responding patients, 8.2 months (95% CI: 3.09 to 13.31) in patients with stable disease and 3.0 months (95% CI: 0 to 8.91) in patients with progressive disease. CONCLUSION: These data suggest that neoadjuvant Oxaliplatin based chemotherapy provides high response rates without increased risk of perioperative morbidity. Response to chemotherapy can lead to long-term recurrence-free survival. Neoadjuvant chemotherapy may identify best candidates for a potentially curative treatment approach. More... »

PAGES

120-120

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/1471-2407-8-120

DOI

http://dx.doi.org/10.1186/1471-2407-8-120

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1037616467

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/18439246


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged, 80 and over", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Combined Chemotherapy Protocols", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Capecitabine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Colorectal Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Deoxycytidine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Fluorouracil", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Leucovorin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Liver Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoadjuvant Therapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasm Recurrence, Local", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Organoplatinum Compounds", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Oxaliplatin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Oxaloacetates", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Medicine, Medical University Vienna, Vienna, Austria", 
          "id": "http://www.grid.ac/institutes/grid.22937.3d", 
          "name": [
            "Department of Medicine, Medical University Vienna, Vienna, Austria"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gruenberger", 
        "givenName": "Birgit", 
        "id": "sg:person.01356576431.32", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01356576431.32"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medicine, Medical University Vienna, Vienna, Austria", 
          "id": "http://www.grid.ac/institutes/grid.22937.3d", 
          "name": [
            "Department of Medicine, Medical University Vienna, Vienna, Austria"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Scheithauer", 
        "givenName": "Werner", 
        "id": "sg:person.0713515512.66", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0713515512.66"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Internal Medicine, LKH Amstetten, Austria", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department of Internal Medicine, LKH Amstetten, Austria"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Punzengruber", 
        "givenName": "Robert", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medicine, Medical University Vienna, Vienna, Austria", 
          "id": "http://www.grid.ac/institutes/grid.22937.3d", 
          "name": [
            "Department of Medicine, Medical University Vienna, Vienna, Austria"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zielinski", 
        "givenName": "Christoph", 
        "id": "sg:person.01201545125.42", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01201545125.42"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Surgery, Medical University Vienna, Vienna, Austria", 
          "id": "http://www.grid.ac/institutes/grid.22937.3d", 
          "name": [
            "Department of Surgery, Medical University Vienna, Vienna, Austria"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tamandl", 
        "givenName": "Dietmar", 
        "id": "sg:person.01307322440.35", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01307322440.35"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Surgery, Medical University Vienna, Vienna, Austria", 
          "id": "http://www.grid.ac/institutes/grid.22937.3d", 
          "name": [
            "Department of Surgery, Medical University Vienna, Vienna, Austria"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gruenberger", 
        "givenName": "Thomas", 
        "id": "sg:person.01156246422.84", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01156246422.84"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s10353-006-0229-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029392862", 
          "https://doi.org/10.1007/s10353-006-0229-9"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/978-1-59745-215-1_10", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021439147", 
          "https://doi.org/10.1007/978-1-59745-215-1_10"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2008-04-25", 
    "datePublishedReg": "2008-04-25", 
    "description": "BACKGROUND: Surgical resection of liver metastases arising from colorectal cancer is considered the only curative treatment option. However, many patients subsequently experience disease recurrence. We prospectively investigated whether neoadjuvant chemotherapy reduces the risk of recurrence following potentially curative liver resection. Special emphasis was directed to the importance of response.\nMETHODS: 50 patients with resectable liver metastases received neoadjuvant XELOX or FOLFOX4 for six cycles (3 months). Complete resection of liver metastases was intended thereafter. Assessments included response rate, postoperative morbidity and recurrence-free survival.\nRESULTS: An objective response was observed in 72% of all patients, including two complete responses. Chemotherapy was well tolerated and the majority of adverse events were mild to moderate (grade 1/2). Potentially curative R0 resection was performed in all patients and postoperative complications were observed in only 12%. The median recurrence-free survival was significantly influenced by tumor response with 24.7 months (95% CI: 4.50 to 44.97) in responding patients, 8.2 months (95% CI: 3.09 to 13.31) in patients with stable disease and 3.0 months (95% CI: 0 to 8.91) in patients with progressive disease.\nCONCLUSION: These data suggest that neoadjuvant Oxaliplatin based chemotherapy provides high response rates without increased risk of perioperative morbidity. Response to chemotherapy can lead to long-term recurrence-free survival. Neoadjuvant chemotherapy may identify best candidates for a potentially curative treatment approach.", 
    "genre": "article", 
    "id": "sg:pub.10.1186/1471-2407-8-120", 
    "inLanguage": "en", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1024632", 
        "issn": [
          "1471-2407"
        ], 
        "name": "BMC Cancer", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "8"
      }
    ], 
    "keywords": [
      "recurrence-free survival", 
      "liver metastases", 
      "neoadjuvant chemotherapy", 
      "long-term recurrence-free survival", 
      "response rate", 
      "colorectal cancer liver metastases", 
      "median recurrence-free survival", 
      "curative liver resection", 
      "resectable liver metastases", 
      "curative R0 resection", 
      "curative treatment option", 
      "cancer liver metastases", 
      "curative treatment approach", 
      "risk of recurrence", 
      "high response rate", 
      "neoadjuvant oxaliplatin", 
      "R0 resection", 
      "stable disease", 
      "postoperative morbidity", 
      "objective response", 
      "postoperative complications", 
      "progressive disease", 
      "perioperative morbidity", 
      "surgical resection", 
      "liver resection", 
      "complete response", 
      "adverse events", 
      "disease recurrence", 
      "complete resection", 
      "colorectal cancer", 
      "treatment options", 
      "tumor response", 
      "chemotherapy", 
      "patients", 
      "treatment approaches", 
      "resection", 
      "importance of response", 
      "metastasis", 
      "months", 
      "morbidity", 
      "recurrence", 
      "survival", 
      "disease", 
      "risk", 
      "response", 
      "XELOX", 
      "FOLFOX4", 
      "complications", 
      "oxaliplatin", 
      "cancer", 
      "rate", 
      "options", 
      "majority", 
      "special emphasis", 
      "assessment", 
      "good candidate", 
      "events", 
      "importance", 
      "candidates", 
      "data", 
      "cycle", 
      "emphasis", 
      "approach", 
      "neoadjuvant XELOX", 
      "curable colorectal cancer liver metastases"
    ], 
    "name": "Importance of response to neoadjuvant chemotherapy in potentially curable colorectal cancer liver metastases", 
    "pagination": "120-120", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1037616467"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/1471-2407-8-120"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "18439246"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/1471-2407-8-120", 
      "https://app.dimensions.ai/details/publication/pub.1037616467"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-01-01T18:19", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220101/entities/gbq_results/article/article_477.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1186/1471-2407-8-120"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/1471-2407-8-120'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/1471-2407-8-120'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/1471-2407-8-120'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/1471-2407-8-120'


 

This table displays all metadata directly associated to this object as RDF triples.

257 TRIPLES      22 PREDICATES      114 URIs      104 LITERALS      28 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/1471-2407-8-120 schema:about N1a308bd97f5f417e94dca18b6b301dc5
2 N1d15dd4445a94032a9f3a29a2d44f827
3 N3093510d480a4b9a87ceb6a81a1a7273
4 N3c88cd89a7f74940aa0dcc16579d0ff7
5 N405d07fa17ec4c6e8f41138a27111e91
6 N42789d97d01d4eefbf6ad268f8a0ed96
7 N534f5767525047c29753f36afb7bfd61
8 N59a4d8ee4c3a4897a906968c24fb4f70
9 N65d58381ceea46db9d0594f8d4ced305
10 N8a0796868ed34a9e8094ce9404b68656
11 N8e315d5e85714539bfb29854b383399e
12 N9542855ac74c4c19b1782bb080e5dbf3
13 Na38bbb21a16746a18b9403b8ac603d3a
14 Na753966d0d214503aec23ef47a662f15
15 Nc18c251d65e44e3e9f6a24a50e367003
16 Nc969acac7d8f47ef9d9aa1050d191176
17 Nd1eeca2f1bdf49b6a55bbda665601157
18 Nd7c66b72a13e4a178bb04d39313ada02
19 Nd8b984214e204db88fb0330a419e21a0
20 Nd8e05e3626a94608bcd1a4943634fe13
21 Nda8a82ea21cf4bd495890c4519ec0668
22 anzsrc-for:11
23 anzsrc-for:1112
24 schema:author Na28b55a731e345988201e4226449cfca
25 schema:citation sg:pub.10.1007/978-1-59745-215-1_10
26 sg:pub.10.1007/s10353-006-0229-9
27 schema:datePublished 2008-04-25
28 schema:datePublishedReg 2008-04-25
29 schema:description BACKGROUND: Surgical resection of liver metastases arising from colorectal cancer is considered the only curative treatment option. However, many patients subsequently experience disease recurrence. We prospectively investigated whether neoadjuvant chemotherapy reduces the risk of recurrence following potentially curative liver resection. Special emphasis was directed to the importance of response. METHODS: 50 patients with resectable liver metastases received neoadjuvant XELOX or FOLFOX4 for six cycles (3 months). Complete resection of liver metastases was intended thereafter. Assessments included response rate, postoperative morbidity and recurrence-free survival. RESULTS: An objective response was observed in 72% of all patients, including two complete responses. Chemotherapy was well tolerated and the majority of adverse events were mild to moderate (grade 1/2). Potentially curative R0 resection was performed in all patients and postoperative complications were observed in only 12%. The median recurrence-free survival was significantly influenced by tumor response with 24.7 months (95% CI: 4.50 to 44.97) in responding patients, 8.2 months (95% CI: 3.09 to 13.31) in patients with stable disease and 3.0 months (95% CI: 0 to 8.91) in patients with progressive disease. CONCLUSION: These data suggest that neoadjuvant Oxaliplatin based chemotherapy provides high response rates without increased risk of perioperative morbidity. Response to chemotherapy can lead to long-term recurrence-free survival. Neoadjuvant chemotherapy may identify best candidates for a potentially curative treatment approach.
30 schema:genre article
31 schema:inLanguage en
32 schema:isAccessibleForFree true
33 schema:isPartOf N96530df11494413f81cca737e456c6c1
34 Naf97170a3b3e4a7892b262ec4502da91
35 sg:journal.1024632
36 schema:keywords FOLFOX4
37 R0 resection
38 XELOX
39 adverse events
40 approach
41 assessment
42 cancer
43 cancer liver metastases
44 candidates
45 chemotherapy
46 colorectal cancer
47 colorectal cancer liver metastases
48 complete resection
49 complete response
50 complications
51 curable colorectal cancer liver metastases
52 curative R0 resection
53 curative liver resection
54 curative treatment approach
55 curative treatment option
56 cycle
57 data
58 disease
59 disease recurrence
60 emphasis
61 events
62 good candidate
63 high response rate
64 importance
65 importance of response
66 liver metastases
67 liver resection
68 long-term recurrence-free survival
69 majority
70 median recurrence-free survival
71 metastasis
72 months
73 morbidity
74 neoadjuvant XELOX
75 neoadjuvant chemotherapy
76 neoadjuvant oxaliplatin
77 objective response
78 options
79 oxaliplatin
80 patients
81 perioperative morbidity
82 postoperative complications
83 postoperative morbidity
84 progressive disease
85 rate
86 recurrence
87 recurrence-free survival
88 resectable liver metastases
89 resection
90 response
91 response rate
92 risk
93 risk of recurrence
94 special emphasis
95 stable disease
96 surgical resection
97 survival
98 treatment approaches
99 treatment options
100 tumor response
101 schema:name Importance of response to neoadjuvant chemotherapy in potentially curable colorectal cancer liver metastases
102 schema:pagination 120-120
103 schema:productId N45031a914bd749cb97bdb4fb29afe0ba
104 N4b3b5c9f222043629486557aac7e3d53
105 N75ff6942d336409abfe8fa75cc822be7
106 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037616467
107 https://doi.org/10.1186/1471-2407-8-120
108 schema:sdDatePublished 2022-01-01T18:19
109 schema:sdLicense https://scigraph.springernature.com/explorer/license/
110 schema:sdPublisher N17c0faaca9294f2e8e3a8841165ef0a9
111 schema:url https://doi.org/10.1186/1471-2407-8-120
112 sgo:license sg:explorer/license/
113 sgo:sdDataset articles
114 rdf:type schema:ScholarlyArticle
115 N0a6ddd3f5e8a43eabb42be6bd51c5de4 rdf:first sg:person.0713515512.66
116 rdf:rest Nec33523dc21344c78635f1c5183b9f53
117 N17c0faaca9294f2e8e3a8841165ef0a9 schema:name Springer Nature - SN SciGraph project
118 rdf:type schema:Organization
119 N1a308bd97f5f417e94dca18b6b301dc5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
120 schema:name Prospective Studies
121 rdf:type schema:DefinedTerm
122 N1d15dd4445a94032a9f3a29a2d44f827 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
123 schema:name Oxaliplatin
124 rdf:type schema:DefinedTerm
125 N3093510d480a4b9a87ceb6a81a1a7273 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
126 schema:name Fluorouracil
127 rdf:type schema:DefinedTerm
128 N315648d59b8e4d9797c3379e123a04b9 rdf:first sg:person.01307322440.35
129 rdf:rest N42b8680ae2c242b4b2a3889e3f781b9b
130 N31aced9f31fc4a4a8900154205c24ae4 schema:affiliation grid-institutes:None
131 schema:familyName Punzengruber
132 schema:givenName Robert
133 rdf:type schema:Person
134 N3c88cd89a7f74940aa0dcc16579d0ff7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
135 schema:name Female
136 rdf:type schema:DefinedTerm
137 N405d07fa17ec4c6e8f41138a27111e91 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Adult
139 rdf:type schema:DefinedTerm
140 N42789d97d01d4eefbf6ad268f8a0ed96 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
141 schema:name Deoxycytidine
142 rdf:type schema:DefinedTerm
143 N42b8680ae2c242b4b2a3889e3f781b9b rdf:first sg:person.01156246422.84
144 rdf:rest rdf:nil
145 N45031a914bd749cb97bdb4fb29afe0ba schema:name doi
146 schema:value 10.1186/1471-2407-8-120
147 rdf:type schema:PropertyValue
148 N4b3b5c9f222043629486557aac7e3d53 schema:name pubmed_id
149 schema:value 18439246
150 rdf:type schema:PropertyValue
151 N534f5767525047c29753f36afb7bfd61 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
152 schema:name Humans
153 rdf:type schema:DefinedTerm
154 N54eec33ffc1d4ac9a8556422adfcd92b rdf:first sg:person.01201545125.42
155 rdf:rest N315648d59b8e4d9797c3379e123a04b9
156 N59a4d8ee4c3a4897a906968c24fb4f70 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
157 schema:name Middle Aged
158 rdf:type schema:DefinedTerm
159 N65d58381ceea46db9d0594f8d4ced305 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
160 schema:name Organoplatinum Compounds
161 rdf:type schema:DefinedTerm
162 N75ff6942d336409abfe8fa75cc822be7 schema:name dimensions_id
163 schema:value pub.1037616467
164 rdf:type schema:PropertyValue
165 N8a0796868ed34a9e8094ce9404b68656 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
166 schema:name Capecitabine
167 rdf:type schema:DefinedTerm
168 N8e315d5e85714539bfb29854b383399e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
169 schema:name Aged
170 rdf:type schema:DefinedTerm
171 N9542855ac74c4c19b1782bb080e5dbf3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
172 schema:name Oxaloacetates
173 rdf:type schema:DefinedTerm
174 N96530df11494413f81cca737e456c6c1 schema:volumeNumber 8
175 rdf:type schema:PublicationVolume
176 Na28b55a731e345988201e4226449cfca rdf:first sg:person.01356576431.32
177 rdf:rest N0a6ddd3f5e8a43eabb42be6bd51c5de4
178 Na38bbb21a16746a18b9403b8ac603d3a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
179 schema:name Male
180 rdf:type schema:DefinedTerm
181 Na753966d0d214503aec23ef47a662f15 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
182 schema:name Neoadjuvant Therapy
183 rdf:type schema:DefinedTerm
184 Naf97170a3b3e4a7892b262ec4502da91 schema:issueNumber 1
185 rdf:type schema:PublicationIssue
186 Nc18c251d65e44e3e9f6a24a50e367003 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
187 schema:name Antineoplastic Combined Chemotherapy Protocols
188 rdf:type schema:DefinedTerm
189 Nc969acac7d8f47ef9d9aa1050d191176 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
190 schema:name Leucovorin
191 rdf:type schema:DefinedTerm
192 Nd1eeca2f1bdf49b6a55bbda665601157 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
193 schema:name Treatment Outcome
194 rdf:type schema:DefinedTerm
195 Nd7c66b72a13e4a178bb04d39313ada02 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
196 schema:name Liver Neoplasms
197 rdf:type schema:DefinedTerm
198 Nd8b984214e204db88fb0330a419e21a0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
199 schema:name Aged, 80 and over
200 rdf:type schema:DefinedTerm
201 Nd8e05e3626a94608bcd1a4943634fe13 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
202 schema:name Colorectal Neoplasms
203 rdf:type schema:DefinedTerm
204 Nda8a82ea21cf4bd495890c4519ec0668 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
205 schema:name Neoplasm Recurrence, Local
206 rdf:type schema:DefinedTerm
207 Nec33523dc21344c78635f1c5183b9f53 rdf:first N31aced9f31fc4a4a8900154205c24ae4
208 rdf:rest N54eec33ffc1d4ac9a8556422adfcd92b
209 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
210 schema:name Medical and Health Sciences
211 rdf:type schema:DefinedTerm
212 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
213 schema:name Oncology and Carcinogenesis
214 rdf:type schema:DefinedTerm
215 sg:journal.1024632 schema:issn 1471-2407
216 schema:name BMC Cancer
217 schema:publisher Springer Nature
218 rdf:type schema:Periodical
219 sg:person.01156246422.84 schema:affiliation grid-institutes:grid.22937.3d
220 schema:familyName Gruenberger
221 schema:givenName Thomas
222 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01156246422.84
223 rdf:type schema:Person
224 sg:person.01201545125.42 schema:affiliation grid-institutes:grid.22937.3d
225 schema:familyName Zielinski
226 schema:givenName Christoph
227 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01201545125.42
228 rdf:type schema:Person
229 sg:person.01307322440.35 schema:affiliation grid-institutes:grid.22937.3d
230 schema:familyName Tamandl
231 schema:givenName Dietmar
232 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01307322440.35
233 rdf:type schema:Person
234 sg:person.01356576431.32 schema:affiliation grid-institutes:grid.22937.3d
235 schema:familyName Gruenberger
236 schema:givenName Birgit
237 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01356576431.32
238 rdf:type schema:Person
239 sg:person.0713515512.66 schema:affiliation grid-institutes:grid.22937.3d
240 schema:familyName Scheithauer
241 schema:givenName Werner
242 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0713515512.66
243 rdf:type schema:Person
244 sg:pub.10.1007/978-1-59745-215-1_10 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021439147
245 https://doi.org/10.1007/978-1-59745-215-1_10
246 rdf:type schema:CreativeWork
247 sg:pub.10.1007/s10353-006-0229-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029392862
248 https://doi.org/10.1007/s10353-006-0229-9
249 rdf:type schema:CreativeWork
250 grid-institutes:None schema:alternateName Department of Internal Medicine, LKH Amstetten, Austria
251 schema:name Department of Internal Medicine, LKH Amstetten, Austria
252 rdf:type schema:Organization
253 grid-institutes:grid.22937.3d schema:alternateName Department of Medicine, Medical University Vienna, Vienna, Austria
254 Department of Surgery, Medical University Vienna, Vienna, Austria
255 schema:name Department of Medicine, Medical University Vienna, Vienna, Austria
256 Department of Surgery, Medical University Vienna, Vienna, Austria
257 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...